Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Runlin Gao

Showing results (261-270 of 326) with videos related to

Pageof 33
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 8, 2020
Impact of unknown diabetes and prediabetes on clinical outcomes in "nondiabetic" Chinese patients after a primary coronary interventionHuanhuan Wang, Ying Song, Xiaofang Tang, et al.
JACC. Cardiovascular Interventions|August 6, 2021
Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCIHao-Yu Wang, Bo Xu, Kefei Dou, et al.
European Heart Journal|August 10, 2014
Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trialWilliam Wijns, Ph Gabriel Steg, Laura Mauri, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|March 25, 2024
Contemporary spectrum, characteristics, and outcomes of adult patients with rheumatic valvular disease in China: Insights from the China-VHD studyZhenya Duan, Yunqing Ye, Zhe Li, et al.
BMC Medical Genomics|January 17, 2024
Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary diseaseYulong Li, Jiawen Li, Xiaofang Tang, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 25, 2022
Prognostic value of modified model for end-stage liver disease scores in patients with significant tricuspid regurgitationJunxing Lv, Yunqing Ye, Zhe Li, et al.
BMC Medicine|July 16, 2023
Assessment of cardio-renal-hepatic function in patients with valvular heart disease: a multi-biomarker approach-the cardio-renal-hepatic scoreJunxing Lv, Bin Zhang, Yunqing Ye, et al.
Angiology|October 28, 2017
Impact of Diabetes Mellitus on Percutaneous Coronary Intervention in Chinese Patients: A Large Single-Center DataHuanhuan Wang, Zhan Gao, Ying Song, et al.
ESC Heart Failure|October 4, 2025
Percutaneous endocardial alginate-hydrogel injection in the treatment of heart failure: First-in-human studyBo Wang, Shuo Wang, Chao Gao, et al.
Frontiers in Cardiovascular Medicine|June 20, 2022
Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel DiseaseTianyu Li, Lin Jiang, Lianjun Xu, et al.
Pageof 33

Showing results (261-270 of 326) with videos related to

Sort By:
Pageof 33
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|March 8, 2020
Impact of unknown diabetes and prediabetes on clinical outcomes in "nondiabetic" Chinese patients after a primary coronary interventionHuanhuan Wang, Ying Song, Xiaofang Tang, et al.
JACC. Cardiovascular Interventions|August 6, 2021
Implications of Periprocedural Myocardial Biomarker Elevations and Commonly Used MI Definitions After Left Main PCIHao-Yu Wang, Bo Xu, Kefei Dou, et al.
European Heart Journal|August 10, 2014
Endeavour zotarolimus-eluting stent reduces stent thrombosis and improves clinical outcomes compared with cypher sirolimus-eluting stent: 4-year results of the PROTECT randomized trialWilliam Wijns, Ph Gabriel Steg, Laura Mauri, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|March 25, 2024
Contemporary spectrum, characteristics, and outcomes of adult patients with rheumatic valvular disease in China: Insights from the China-VHD studyZhenya Duan, Yunqing Ye, Zhe Li, et al.
BMC Medical Genomics|January 17, 2024
Association of NPC1L1 and HMGCR gene polymorphisms with coronary artery calcification in patients with premature triple-vessel coronary diseaseYulong Li, Jiawen Li, Xiaofang Tang, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 25, 2022
Prognostic value of modified model for end-stage liver disease scores in patients with significant tricuspid regurgitationJunxing Lv, Yunqing Ye, Zhe Li, et al.
BMC Medicine|July 16, 2023
Assessment of cardio-renal-hepatic function in patients with valvular heart disease: a multi-biomarker approach-the cardio-renal-hepatic scoreJunxing Lv, Bin Zhang, Yunqing Ye, et al.
Angiology|October 28, 2017
Impact of Diabetes Mellitus on Percutaneous Coronary Intervention in Chinese Patients: A Large Single-Center DataHuanhuan Wang, Zhan Gao, Ying Song, et al.
ESC Heart Failure|October 4, 2025
Percutaneous endocardial alginate-hydrogel injection in the treatment of heart failure: First-in-human studyBo Wang, Shuo Wang, Chao Gao, et al.
Frontiers in Cardiovascular Medicine|June 20, 2022
Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel DiseaseTianyu Li, Lin Jiang, Lianjun Xu, et al.
Pageof 33